Content continues after advertisement

Research Note: Cardiovascular Effects of Fentanyl IV in Anesthetized Cats


|November/December 2021

Sign in to Print/View PDF

Fentanyl, a mu-opioid agonist, is used to decrease inhaled anesthetic intake, which may improve hemodynamics during anesthesia. The cardiovascular effect of fentanyl varies among species, but most patients become bradycardic. This study sought to determine the cardiopulmonary effects of fentanyl IV administration in cats anesthetized with isoflurane and during anesthetic recovery when acepromazine or dexmedetomidine was administered concurrently. Results indicated that healthy cats anesthetized with isoflurane experienced improved cardiovascular function without respiratory compromise following fentanyl administration. Cardiovascular effects of dexmedetomidine and acepromazine during anesthetic recovery differed, but the measured cardiopulmonary parameters stayed within acceptable limits.


For global readers, a calculator to convert laboratory values, dosages, and other measurements to SI units can be found here.

All Clinician's Brief content is reviewed for accuracy at the time of publication. Previously published content may not reflect recent developments in research and practice.

Material from Clinician's Brief may not be reproduced, distributed, or used in whole or in part without prior permission of Educational Concepts, LLC. For questions or inquiries please contact us.


Clinician's Brief:
The Podcast
Listen as host Alyssa Watson, DVM, talks with the authors of your favorite Clinician’s Brief articles. Dig deeper and explore the conversations behind the content here.
Clinician's Brief provides relevant diagnostic and treatment information for small animal practitioners. It has been ranked the #1 most essential publication by small animal veterinarians for 9 years.*

*2007-2017 PERQ and Essential Media Studies

© 2023 Educational Concepts, L.L.C. dba Brief Media ™ All Rights Reserved. Terms & Conditions | DMCA Copyright | Privacy Policy | Acceptable Use Policy